REZOLVE-AA

Advertisement

cGxPJobs Banner

Nektar Rezpegaldesleukin Shows 52-Week Alopecia Results

SAN FRANCISCO, April 20, 2026 Nektar Therapeutics has reported compelling 52-week topline results from the Phase 2b REZOLVE-AA trial,...

By cGxPwire Editor
April 21, 2026

Read More

Advertisement

cGxPJobs

Directory